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Abstract.  We have raised a  rabbit antiserum against a 
synthetic peptide corresponding to the cleavage site be- 
tween [3-1ipotropic  hormone and the ACTH moieties of 
murine pro-opiomelanocortin (POMC).  After affinity 
purification, the anti-cleavage site antibody im- 
munoprecipitates POMC from extracts of AtT20 cells 
but it does not immunoprecipitate the ACTH in such 
extracts or any of the other products of cleavage of 
POMC. By contrast, an antiserum raised against pure 
swine ACTH immunoprecipitates both POMC and 
ACTH from AtT20 cell extracts. Using the anti- 
cleavage site antibody we have shown that all the 
POMC synthesized during a  15-min pulse-labeling 
with [3~S]methionine is cleaved at this site within 1 h. 
By immunoelectron microscopy we show that 
'~25-30%  of peripheral secretory granules in AtT20 
cells can be labeled with the anti-cleavage site anti- 
body while anti-ACTH antiserum labels all these gran- 
ules. This establishes that at least some POMC is 
packaged into secretory granules before its proteolytic 
cleavage. 
p 
RO-OPIOMELANOCORTIN (POMC) 1 is  a  polyprotein 
which contains the sequences of several biologically 
active peptides including ACTH,  13-endorphin, and 
~t-melanocyte-stimulating hormone. The amino acid sequence 
of murine POMC has been predicted from the nucleotide se- 
quence of POMC cDNA (22, 30).  In ART20 cells, a line of 
murine  anterior  pituitary  tumor  cells  (10), cleavage  of 
POMC liberates ACrH, ~lipotropic hormone (I]LPH), and 
an amino-terminal peptide (5, 17, 25). Some of the I3LPH is 
cleaved further to yield 13-endorphin while the amino-termi- 
nal peptide is cleaved to yield from its carboxy end the join- 
ing peptide whose carboxy terminus is ~t-amidated (8). The 
ACTH does not, however,  undergo further cleavage.  In the 
intermediate lobe of the pituitary, however,  ACq'H, as well 
as I3LPH and the amino-terminal fragment are all cleaved 
again (25). All of  these cleavages of POMC, and its products, 
occur at the sites of pairs of basic amino acids, various com- 
binations  of lysine and arginine residues.  Each  cleavage 
eliminates the two basic amino acids at that site but the re- 
mainder of the polypeptide chain is conserved. Antibodies 
against the products of cleavage are likely, therefore, also to 
recognize the precursor molecule. The cleavage sites them- 
selves, however,  must be specific for POMC since they are 
eliminated by cleavage, which involves excision of the two 
basic amino acids. Pursuing this reasoning we raised a rabbit 
1.  Abbreviations  used in tiffs paper:  KLH, Keyhole Limpet hemocyanin; 
I3LPH,  13-1ipotropic hormone; POMC, pro-opiomelanocortin. 
antiserum to a synthetic peptide with a sequence correspond- 
ing to eight amino acids at the ACTH-13LPH  cleavage site 
of murine POMC, and affinity purified the antiserum using 
a synthetic peptide corresponding to six amino acids of this 
site. The resultant antibody proved to be specific for POMC 
and here we describe its characterization and results obtained 
using it to study the sorting of  POMC into the secretory gran- 
ules of AtT20 cells. 
Materials and Methods 
Peptide Synthesis 
Three peptides were synthesized  as indicated in Fig. 1. The longest of  them, 
a  nonapeptide, had the sequence Lys-Leu-Glu-Phe-Lys-Arg-Glu-Leu-Glu 
and corresponds to the eight amino acids of the cleavage site between the 
ACTH and I~LPH moieties of murine POMC (22, 30) with an additional 
amino-terminal lysine residue. This peptide was used for immunization of 
rabbits (see below). The second  peptide had the sequence Lys-Glu-Phe-Lys- 
Arg-Glu-Leu and was used to affinity purify the antisera raised against the 
longest peptide (see below). Finally a peptide, Glu-Leu-Glu-Gly-Glu, cor- 
responding to the amino terminus of murine I~LPH (22, 30), was made and 
used as described in the text. 
The peptides were synthesized in a  continuous flow instrument con- 
strutted in our laboratory (9).  Synthesis was performed on a  1%  cross- 
linked polystyrene support using fluorenylmethoxycarbonyl  amino acids (3) 
and in situ activation with benz°triaz°lyl-tris-(dimethylamin°)-ph°sph°ni- 
umhexatluorophosphate (4). The synthetic peptides were purified by high- 
pressure liquid chromatography. 
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Figure 1.  A  diagram of murine POMC showing the cleavage sites 
between the amino-terminal peptide and the ACTH and I~LPH moi- 
eties (the amino-terminal signal peptide responsible for leading the 
polypeptide chain into the lumen of the rough endoplasmic reticu- 
lum is not shown since it is cleaved off during translocation); (A) 
the amino acid sequence around the ACTH-13LPH cleavage site; (B, 
C,  D) the three peptides that were chemically synthesized. 
Antibody Production 
We followed exactly the procedure described by Kreis (18) in which the anti- 
gen, in our case the nonapeptide and also swine ACTH,  is coupled using 
electron microscopic grade glutaraidehyde  to Keyhole Limpet hemocyanin 
(KLH)  obtained from  Calbioehem-Behring Corp.  (La Jolla,  CA).  The 
antigen-KLH was then emulsified with complete Freund's adjuvant (Gibeo, 
Grand Island, NY) before use for immunization. Two antisera were raised 
in rabbits, one against the peptide corresponding to the 13LPH-ACTH cleav- 
age site (see above), the other against swine ACTH (Serva, Heidelberg).  An 
antiserum against swine ACTH was also raised in a guinea pig. The anti- 
ACTH antisera were not affinity purified since immunofluorescence  and im- 
munoblotting tests showed them to be specific for ACTH and of a high titer. 
The antiserum against the cleavage site peptide was affinity purified  on a 
column of CNBr-activated  Sepharose 4B (Pharmacia, Uppsala)  to which 
was coupled the shorter synthetic peptide CLys-Glu-Phe-Lys-Arg-Glu-Leu). 
The affinity-purified antibody is referred to here as anti-POMC-CS. 
Cell Culture 
AtT20D16V cells were grown in Falcon plastic ware in DME supplemented 
with 3.5 g/liter of glucose and 10% FCS or horse serum (Gibco).  The cells 
were replated  after dispersion of clumps with 0.52% trypsin and 0.05% 
EDTA every 5-7 d. Under these culture conditions the cell population dou- 
bles in '~40 h (28). 
Indirect lmmunofluorescence Microscopy 
AtT20 cells grown on glass coverslips  were fixed, permeabilized, and la- 
beled with antibodies using the procedures described by Ash et al. (1). As 
first antibodies we used the affinity-purified POMC-CS and either rabbit or 
guinea pig anti-ACTH andsera as described in the figure legends. The sec- 
ond antibodies were  affinity  purified rhodamine-cenjugated sheep anti- 
rabbit and fluorescein-conjugated  goat anti-guinea pig antibodies.  In some 
experiments,  as indicated in the legends, the first antibodies were preincu- 
bated at room temperature for 30 rain with either 1 mg/ml swine ACTH or 
1 mg/ml of the pentapeptide,  Glu-Leu-Glu-Gly-Glu,  or 1 mg/ml of the hep- 
tapeptide  used to affinity purify the anti-POMC-CS. The ACTH and the 
peptides were also present at 1 mg/ml during the 20-rain labeling with the 
first antibodies. 
Mouse anterior pituitaries were dissected out and fixed for 10 rain in 4% 
paraforrnaldehyde in 200 mM Pipes, pH 7.2, at 4°C and then in 8 % parafor- 
maldehyde in the same buffer for 50 min at room temperature.  The tissue 
blocks were then infused with 2.1 M sucrose and frozen in liquid nitrogen. 
1-gm thick sections were cut of the fixed frozen tissue,  mounted on glass 
slides, and labeled with the antibodies using the procedure of Ash et al. (1). 
lmmunoelectron Microscopy 
ART20 cells were fixed for 10 iron in 4 % paraformaldehyde  in 200 mM Pipes 
buffer, pH 7.2, and then for 50 min at room temperature in 8% parafor- 
maldehyde  in the same buffer.  The cells were scraped from the dishes, 
washed, infiltrated with 2.1 M sucrose, and frozen in liquid nitrogen.  Thin 
sections were cut and labeled according to established procedures (14, 26, 
27). The antibodies used were anti-POMC-CS and guinea pig anti-ACTH 
antisera as specified in the legends. After incubation with these antibodies, 
the sections were labeled with protein A conjugated to either 5, 8, or 10 nm 
gold.  The sections were contrasted with uranyl acetate before being exam- 
ined in Philips electron microscopes. 
Immunoprecipitation 
AtT20 cells grown in 6-cm tissue culture petri dishes were labeled with 250 
~tCi of [35S]methionine in 1 ml of methionine-free growth medium (MEMo 
Met containing dialyzed FCS) for the times indicated in Fig. 6. After label- 
ing, some cultures were chased for 1 h by the addition of 4 ml of normal 
growth medium supplemented  with 0.15 mg/ml of unlabeled methionine. 
For immunoprecipitation analysis,  cells in each dish were solubilized in 
1 ml of a solution containing 50 mM Tris-HCi, pH 7.4,  100 mM NaCI, 
0.4% SDS, 40 Ixg/ml PMSF. DNA was sheared by repeated passage through 
a 21-gauge needle fitted to a  1-ml syringe.  After a 5-min centrifugation in 
an Eppendorf centrifuge,  Triton X-100 was added to each supernatant, from 
a 20%  stock  solution in H20,  to yield a final concentration of 2%.  The 
centrifugation step was then repeated  and the supernatants  were retained. 
10 ttg of affinity-purified anti-POMC-CS or 10 ttl of anti-ACrH antiserum 
was added to each sample followed by 20 lxl of a 50% suspension of protein 
A-Sepharose (Pharmacia). These samples were then incubated for 16 h at 
4°C on an end over end rotator.  The Sepharose  was subsequently  washed 
five times in a solution containing 50 mM Tris-HCl, pH 7.4, 100 mM NaCI, 
0.1% SDS, 0.5% Triton X-100, 40 I~g/ml PMSF, followed by two washes in 
50 mM Tris-HC1,  pH 7.4. The immunoprecipitates  were then solubllized 
in I00 gl of SDS gel sample buffer and the samples fractionated on a 10-18  % 
polyacrylamide  gradient gel.  Gels were  impregnated  with EN3HANCE 
(New England Nuclear,  Boston, MA), dried, and exposed  at -80°C. 
Results 
Production of  Antibody against Cleavage Site Peptide 
In murine POMC, the amino acid sequence at the cleavage 
site between the ACTH and 13LPH moieties is Leu-Glu-Phe- 
Lys-Arg-Glu-Leu-Glu (see Fig.  2).  This  sequence is also 
present in rat POMC and closely related sequences occur in 
bovine and human POMC. A synthetic peptide comprising 
an  amino-terminal lysine residue followed by these eight 
amino acids was synthesized and linked, using glutaralde- 
hyde, to KLH. The additional amino-terminal lysine residue 
was added to facilitate this linkage. One of two rabbits im- 
munized with KLH-peptide emulsified in complete Freund's 
adjuvant gave, after two boosts, an antiserum that labeled cy- 
toplasmic granules in AtT20 cells above a high nonspecific 
background. The second rabbit's serum did not label AtT20 
Figures 2-4.  (Fig. 2 A) An AfI20 cell labeled with anti-POMC-CS and rhodamine-conjugated second antibody. Note the labeling of the 
tips of the cell projections and the light perinuclear labeling; (Fig. 2 B) the same cell viewed with Nomarski optics; (Fig. 2 C) for compari- 
son, an ART20 cell labeled with rabbit anti-ACTH antiserum; (D) the same Cell under Nomarski optics. (Fig. 3) Two ART20 cells incubated 
first for 20 min at room temperature with guinea pig antiserum against ACTH at fivefold the concentration used to label cells for ACTH 
and then incubated with anti-POMC-CS followed by rhodamine-conjugated anti-rabbit second antibody. Preincubation with guinea pig 
anti-ACTH antiserum does not block labeling with anti-POMC-CS. Perinuclear labeling of the Golgi region by anti-POMC-CS is particu- 
larly clear in these two cells. (Fig. 4 A) An ART20 cell labeled with anti-POMC-CS which was incubated at room temperature for 30 min 
with 1 mg/ml swine ACTH before the labeling and during the 20 min of labeling. The incubation of anti-POMC-CS with ACrH does 
not block its ability to label the cells. (Fig. 4 B) The same cell viewed with Nomarski optics.  Bars,  10 ~tm. 
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found,  by  dot blot  analysis  (not  shown),  to  cross-react 
slightly with ACrH. It was therefore affinity purified on a 
column consisting of the shorter peptide, Lys-Glu-Phe-Lys- 
Arg-Glu-Leu, coupled to cyanogen  bromide Sepharose. The 
last six amino acids of  this peptide correspond to the last two 
amino acids of ACTH, the dibasic cleavage site and the first 
two amino acids of I~LPH. The afffinity-purified antibody 
eluted  from this  column,  designated anti-POMC-CS,  no 
longer recognized AC'rH. It was subsequently characterized 
to establish its specificity for the cleavage site in POMC. 
Indirect Immunofluorescence Labeling with 
Anti-POMC-CS 
In AtT20  cells processed for indirect immunottuorescence 
microscopy with the affinity-purified  anti-POMC-CS, gran- 
ules in both the tips of projections from the cells and the 
Golgi region were labeled (Figs. 2 A and 3). This pattern of 
labeling resembles but, particularly in the Golgi region, is 
less  intense than that obtained with guinea pig or rabbit 
anti-ACTH antisera (Fig. 2 C). To show that the POMC-CS 
was not labeling either ACTH or 13LPH  in the secretory gran- 
ules we did the following experiments. (a) In a double label- 
ing procedure AtT20  cells were incubated with guinea pig 
anti-ACTH antiserum but no second antibody and then with 
anti-POMC-CS and rhodamine anti-rabbit second antibody. 
The preincubatlon with antiserum against ACTH did not 
block subsequent labeling with POMC-CS (Fig. 3). (b) An- 
ti-POMC-CS was incubated at room temperature for 30 min 
with swine ACTH at 1 mg/ml. All20 cells were then labeled 
with this anti-POMC-CS in the presence of I mg/ml ACTH. 
The ACTH did not block the labeling of secretory granules 
in AtT20 cells by anti-POMC-CS (Fig. 4). In contrast incu- 
bation of anti-ACTH antiserum with 1 mg/mi ACTH com- 
pletely blocked labeling of secretory granules (not shown). 
(c) This experiment was repeated using at 1 mg/ml a syn- 
thetic peptide (Glu-Leu-Glu-Gly-Glu) corresponding to the 
first five amino acids of murine 13LPH instead of ACTH. 
Again, incubation of anti-POMC-CS with this peptide, or 
with the peptide and ACTH together, did not block labeling 
of secretory granules in AtT20  cells (Fig.  5).  (d)  We in- 
cubated the anti-POMC-CS  with  1 mg/ml of the peptide 
used for its affinity purification, namely Lys-Glu-Phe-Lys- 
Arg-Glu-Leu.  This  completely abolished  the  labeling  of 
ART20 cells (not shown). On the other hand, incubation of 
anti-ACTH antisera with each of the three synthetic peptides 
used in this study at 1 mg/ml did not block labeling of the 
ACTH in the secretory granules (not shown). 
These results established that anti-POMC-CS labeled an 
epitope in secretory granules of AtT20  cells which is not 
present in ACTH or the first five amino acids of I3LHP. The 
antibody thus appeared to be specific for POMC. This was 
proven by immunoblotting and immunoprecipitation experi- 
ments. 
Immunoprecipitation of  POMC  by Anti-POMC-CS 
After the characterization of anti-POMC-CS by immunoflu- 
orescence microscopy we established by dot blots on nitro- 
cellulose strips  that the antibody failed to bind to  swine 
ACTH (not shown). We then used the anti-POMC-CS and 
a  rabbit antiserum against ACTH in immunoprecipitation 
analyses  of  AtT20  cells  labeled  for  various  times  with 
[3SS]methionine (Fig. 6).  After a  15-min pulse-label, both 
of these antibodies specifically precipitated only POMC, the 
ACrH and DLPH precursor molecule. However, after a 60- 
rain incubation ("chase") in the presence of excess unlabeled 
methionine the anti-ACrH antiserum immunoprecipitated 
mature ACTH whereas the anti-POMC-CS failed to precipi- 
tate specifically any labeled protein. If, however, we labeled 
cells continuously for 75 rain, the duration of the previous 
pulse and chase, we found that while anti-POMC-CS still 
only precipitated POMC, the anti-ACTH antiserum precipi- 
Figure 5. (.4) An Afr20 cell labeled with anti-POMC-CS which had been incubated for 30 rain at room temperature with 1 mg/ml of the 
gentapcptide Glu-Lcu-Glu-Gly-Glu  together with 1 mg/ml of swine ACrH. Incubation of anti-POMC-CS with this peptide, the amino- 
terminal sequence of murine [3LPH, does not block its ability to label the cells. We consistently observed some reduction in labeling of 
AtT20 cells when either anti-POMC-CS or anti-ACrH antiserum was preincubated with 1 mg/ml of the pentapeptide. This we attribute 
to nonspecific effects of the presence of such a high concentration of such an acidic peptide before and during labeling. (B) The same 
cell viewed by Nomarski optics. Bars, 10 I~rn. 
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ACTH antiserum  using either anti-ACTH (lanes 2-4)  or anti- 
POMC-CS (lanes 5-7). Cells were pulse-labeled with [35S]methi- 
onine for 15 min (P), pulse-labeled for 15 min and chased for 1 h 
(Ch), or labeled continuously for 75 min (C). After a 15-min  pulse 
only  POMC  is  precipitated  by  both  anti-ACTH  (lane  2)  and 
anti-POMC-CS  (lane 5).  After a  1-h chase all of the POMC is 
processed to yield mature ACTH (lane 3) and 13LPH, neither of 
which is precipitated by the anti-POMC-CS (lane 6). After 75 min 
continuous label anti-ACTH precipitated both POMC and ACrH 
but  also  an  intermediate  ,x,27,000-mol-wt peptide  (lane  4). 
Anti-POMC-CS  on the other hand precipitates only POMC (lane 
7).  This  suggests that the 27,000-mol-wt peptide seen in lane 4 
results from the cleavage of 13LPH from POMC. Lane 1 shows the 
total ACTH extract after the  15 min pulse label.  100 times this 
amount was used in each immunoprecipitation. It is worth noting 
that the anti-ACTH apparently has a lower affinity for POMC than 
for mature AClrH (compare lanes 2, 3, and 5). The bands with mo- 
lecular weights greater than POMC appeared variably in our im- 
munoprecipitates. 
tated not only POMC and ACTH but also a third polypeptide 
of intermediate molecular weight; from its mobility on the 
gels we estimate its molecular weight to be about 27,000. 
We conclude from these results that anti-POMC-CS  is 
specific for POMC in AtT20 cells and secondly that POMC 
is completely processed within 1 h of its synthesis. A third 
possible conclusion is that the cleavage of the site in POMC 
between 13LPH and ACTH, against which anti-POMC-CS is 
directed, occurs on average before the cleavage of the site be- 
tween ACTH and the amino-terminal peptide, thereby gener- 
ating an intermediate, with an apparent molecular weight of 
27,000,  containing  the  ACTH  sequence  but  lacking  the 
ACTH-13LPH  cleavage  site.  This,  however,  is  contingent 
upon the demonstration that the 27-kD peptide contains the 
POMC amino terminus and that it can be "chased" to yield 
ACTH. These experiments have not so far been performed. 
Secretory Granules Contain POMC 
The  pattern  of  indirect  immunofluorescence  labeling  of 
AtT20 cells with anti-POMC-CS strongly suggested that the 
antibody was recognizing a  component of secretory gran- 
ules. To prove this at the level of resolution of the electron 
microscope we cut cryosections of AtT20 cells and labeled 
them by the immunogold procedure with either anti-POMC- 
CS, guinea pig anti-ACTH antiserum, or both antibodies in 
a double labeling procedure. While the anti-ACTH antise- 
rum when used alone labeled all the peripheral secretory 
granules  (not  shown),  the  anti-POMC-CS  antibodies  la- 
beled only some of them (Fig. 7). Counts of the proportion 
of granules  labeled  with  anti-POMC-CS,  in  which  only 
granules with three or more gold particles over their cores 
were scored as positive, indicated that between 25 and 30% 
of the granules at the cell periphery contain POMC. This es- 
tablishes that at least a quarter to a third of peripheral secre- 
tory granules contain POMC  that has not been cleaved at 
the site between ACTH and 13LPH, which is apparently the 
first site to undergo cleavage during maturation of POMC in 
these cells.  The double labeling of the granules with the 
anti-POMC-CS and guinea pig anti-ACTH antibodies (Fig. 
8)  confirmed the  results  of indirect immunofluorescence, 
which showed that the epitope recognized by anti-POMC- 
CS is not competed for by anti-AcrI-I antiserum. We were 
also able to confirm at the level of resolution of the electron 
microscope the labeling by anti-POMC-CS and anti-ACTH 
antiserum of immature peri Golgi secretory granules (Fig. 9). 
Crossreactivity of  Anti-POMC-CS Antibody 
Anti-POMC-CS is specific for POMC in AtT20 cells as evi- 
denced by the results of immunoprecipitation experiments 
and electron microscopic immunocytochemistry described 
above. We have used the antibody for indirect immunofluo- 
rescence labeling of 1-~tm thick sections of mouse anterior 
pituitary tissue. The corticotrophs, which can easily be rec- 
ognized by their irregular shape and by labeling with the 
guinea pig anti-ACTH antiserum (Fig. 10 A), are also labeled 
by anti-POMC-CS  in a double labeling experiment as ex- 
pected (Fig.  10 B). However, in the anterior pituitary sec- 
tions a second type of cell, clearly distinct from the cortico- 
trophs,  is  strongly labeled by anti-POMC-CS  but not by 
anti-ACTH antiserum (Fig. 10 B). We have not yet identified 
this other positive cell type; such identification will require 
additional light and electron microscopic immunocytochem- 
ical studies. 
Discussion 
The experiments presented here show that using quite short 
synthetic peptides it is possible to obtain an antibody specific 
for a  single dibasic amino acid cleavage site in a  prohor- 
mone, POMC, which has eight potential cleavage sites of  this 
type. The antibody specifically immunoprecipitates POMC 
from extracts of AtT20 cells and labels specifically periph- 
eral secretory granules in these cells. In sections of mouse 
anterior  pituitary  processed  for  indirect  immunofluores- 
Tooze et al. POMC Is Packaged  into Secretory  Granules before  Cleavage  159 Figures  7-9. (Fig.  7) Secretory granules in AtT20 cells labeled with anti-POMC-CS.  This field shows four secretory granules below the 
plasma membrane of two AtT20 ceils. Two of the granules (open arrows) are labeled to different extents (four gold particles over one and 
11 over the other) while two others (solid arrows) are unlabeled. The single gold particle over one of these two granules is not considered 
significant. Mitochondria are not labeled. The arrowhead indicates a cisterna of the rough endoplasmic reticulum. As is usual in cryothin 
sections the ribosomes are not visible.  (F/g. 8) Secretory granules in AtT20 cells double labeled first with anti-POMC-CS followed by 
protein A conjugated to ~10 nm gold and then with anti-ACTH antiserum followed by 5 nm gold. In this selected field all of the secretory 
granules are labeled with both large and small gold indicating the presence of POMC as well as ACTH in all of them. Counts of a larger 
representative sample, however, showed that only 25-30% of all peripheral granules contain POMC. (Fig. 9) A Golgi region in a frozen 
thin section of  an AtT20 cell. The section was labeled with anti-ACTH antiserum followed by 5 nm gold and then anti-POMC-CS followed 
by 10 nm gold. The Golgi stack (G) is unlabeled by the immunogold technique, as in a previous study where the reasons for this are discussed 
(29), but peri Golgi immature secretory granules  (arrow) are labeled by both antibodies. Bars, 0.1  lun. 
cence, the anti-POMC-CS labels in addition to the cortico- 
trophs synthesizing POMC a  second class of cells. 
One obvious possibility is that the anti-POMC-CS is rec- 
ognizing another cleavage site in a different polypeptide hor- 
mone precursor synthesized in these clearly different cells. 
The other less interesting possibility is that we are seeing a 
chance crossreactivity with some other protein specific to 
these ceils. Indeed, we have noticed that our affinity-purified 
anti-POMC-CS antibody shows a very specific, but presum- 
ably trivial crossreactivity with  the  intermediate filament 
protein vimentin. This was demonstrated by immunoprecipi- 
tation,  immunoblotting,  and  immunofluorescence micros- 
copy (not shown). While this may restrict the use of the anti- 
body, the conclusions arrived at in this paper remain valid 
since AtT20 cells and epithelial neurosecretory cells of the 
anterior pituitary do not contain vimentin. In this context it 
is interesting to note that a number of groups have reported 
monoclonal and antipeptide antibodies against diverse pro- 
teins, e.g., thyl and pp60  ~'~ (6, 21),  which apparently cross 
react with vimentin. Presumably vimentin exhibits structural 
features which are common to a variety of proteins. 
Our immunoprecipitation experiments establish that with- 
in I h of its synthesis POMC in AtT20 cells is cleaved at the 
site between ACTH and I~LPH. Furthermore,  comparison 
of the  results of immunoprecipitations of SDS  extracts of 
[35S]methionine-labeled AtT20  cells using  anti-ACTH an- 
tiserurn  and  anti-POMC-CS  is  consistent  with  previous 
findings (7, 19, 24) that this site is cleaved before the cleavage 
between the amino-terminal peptide and the AC'rH moiety. 
We have also shown that 25-30 % of the secretory granules 
at the cell periphery in cryosections of AtT20 cells can be 
labeled above background using anti-POMC-CS and the im- 
munogold labeling procedure. Combining these two sets of 
observations we can reach two conclusions concerning the 
sorting and packaging of POMC into secretory granules of 
the regulated pathway of AtT20 ceils. First our results clearly 
indicate that at least some POMC is sorted and packaged into 
the cores of the secretory granules before its cleavage at the 
ACTH-13LPH site. And, since this site is cleaved first, this 
POMC must be sorted and packaged before it has undergone 
any proteolytic maturation.  This observation is  consistent 
with biochemical evidence that in cells of the rat intermedi- 
The Journal of Cell Biology, Volume 105,  1987  160 Figure 10. A 1-gm-thick frozen section of mouse anterior pituitary double labeled with guinea pig anti-ACrH antiserum and fluorescein- 
conjugated second antibody (A) followed by anti-POMC-CS  and rhodamine-conjugated second antibody (B). Corticotrophs are labeled 
by both antibodies. The similarity in the pattern of labeling of these cells by the two antibodies indicates that peripheral secretory granules, 
which line up in a layer below the plasma membrane and therefore after labeling reveal the outline of the cell, contain POMC. In addition 
to the corticotrophs a second cell type is labeled with anti-POMC-CS  (arrows in B) but not by anti-ACrH antiserum. We have not yet 
identified this cell type but its shape and distribution indicate that it is one of the other neurosecretory cells in this tissue. (C) Phase-contrast 
micrograph of the same field as shown in A and B. A star marks the same corticotroph in all three micrographs. Bars,  10 Ixm. 
ate pituitary some POMC enters secretory granules before 
cleavage (12). In this respect, AtT20 cells also resemble neu- 
rosecretory neurons in the pituitary producing either vaso- 
pressin or oxytocin, where at least some cleavage of prohor- 
mone occurs in the secretory granules while they are moving 
down the long axons of these cells (2, 11). Moreover, in pan- 
creatic  cells  producing  insulin,  packaging  also  precedes 
cleavage of the prohormone (23). We cannot, of course, con- 
clude that sorting and packaging of POMC  in AtT20 cells 
obligatorily precedes its cleavage. On the other hand sorting 
before cleavage is the simplest interpretation of our findings 
and also the fact that all three cleavage products of POMC 
are present in the secretory granules of AtT20 cells (15). The 
identical pattern of immunofluorescence labeling by anti- 
POMC-CS and anti-AOl'H antiserum of the corticotrophs in 
mouse anterior pituitary tissue indicates that the peripheral 
secretory granules  that line  the  inner  face of the plasma 
membrane of these cells also contain some POMC. 
The packaging of POMC into the cores of secretory gran- 
ules occurs in the trans-most compartment of the Golgi ap- 
paratus  (29) and is followed by migration of the secretory 
granules to the cell periphery. Since POMC is cleaved within 
an hour of its synthesis, peripheral secretory granules con- 
taining POMC must be <1 h old, if the POMC in the periph- 
eral granules continues to undergo cleavage. Presumably that 
is the case because mature secretory granules, the densest 
population of granules isolated from AtT20 cells, contain the 
three  POMC  cleavage  products  but  they  do  not  contain 
POMC  itself (15). 
The immunogold labeling technique is  quantitative (13) 
and  is  particularly  valuable  for  determining  the  relative 
amounts  of an  antigen  in  one compartment;  for example 
secretory granules.  The three- to four-fold variation in the 
extent of labeling of peripheral  secretory granules  in  the 
same thin sections of the same or adjacent cells (Fig. 7) indi- 
cates, therefore, a three- to fourfold variation in the amount 
of POMC in individual granules. We interpret this to mean 
that we are looking at a heterogeneous population of secre- 
tory granules in which cleavage of POMC is progressing to 
completion.  Further  immunocytochemical  studies  of the 
processing of POMC and the formation of secretory granules 
in AtT20 cells using anti-POMC-CS are under way. At the 
outset of this work we hoped that an antibody specific for 
POMC would provide a probe for the identification by im- 
munoelectron microscopy of post-Golgi vesicles of the con- 
stitutive exocytic pathway that externalize uncleaved POMC 
(16). However, to date we have failed to identify such vesicles 
with anti-POMC-CS in frozen thin sections. It may be that 
the amount of POMC  in  individual vesicles is below the 
threshold of  detection by the immunogold technique. Adding 
chloroquine to cells and diverting all the POMC into the con- 
stitutive pathway (20) may be one way to improve the chances 
of detecting the constitutive exocytic vesicles. 
AtT20 cells and POMC provided a convenient model sys- 
tem in which to establish the feasibility of  producing antibod- 
ies  against  specific dibasic  endoproteolytic cleavage.  The 
results suggest that our approach may be generally useful and 
that it should be possible to obtain antibodies specific for 
such  cleavage sites  in  other prohormones using  synthetic 
peptides. 
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